Zarządzanie w profilaktyce i leczeniu nowotworów u człowieka na przykładzie suplementacji selenem (Se) - część II

• Autorzy: Katarzyna Sygit , Marian Sygit , Jan Krakowiak , Krzysztof Sieja

Warianty tytułu

Management of Oncological Prophylaxis and Human Cancer Treatment on the Example of Selenium (Se) Supplementation - Part II

• Języki publikacji: PL

Abstrakty

EN

Introduction. The persistent high incidence of civilization diseases, including can- cer, prompts numerous research teams to look for their causes, methods of prevention and effective therapeutic measures. In recent years, selenium has become more and more popular as a naturally occurring component with the potential to reduce carcinogenesis processes. Objective. The aim of this work is to indicate in the management of prophylaxis and treatment of human cancers the influence of selenium (Se) as an important element that reduces the risk of cancer. Description. The level of selenium in the blood serum is an indicator of high risk: lung cancer, la- ryngeal cancer, colon cancer, stomach cancer, pancreatic cancer, as well as breast and ovarian cancer. There is a strong relationship between selenium and the incidence of cancer. Nume- rous studies conducted in Poland and around the world have shown a strong correlation between selenium concentration and cancer risk. The lower the concentration, the greater the risk of getting sick. This applies to the most common cancers, such as lung cancer, colon cancer and pancreas. Summary. In many clinical and experimental studies carried out nationally and interna- tionally, evidence has been gathered clearly indicating the important role played by selenium (Se) in prevention and treatment, especially of cancer.

Słowa kluczowe

PL

Profilaktyka zdrowotna; Medycyna

EN

Preventive health care; Medicine

• Czasopismo: Przedsiębiorczość i Zarządzanie
• Rocznik: 2018
• Numer: t. 19, z. 12, cz. 2 Współczesne problemy zarządzania publicznego
• Strony: 355--366

Twórcy

autor

Katarzyna Sygit

• Uniwersytet Szczeciński

autor

Marian Sygit

• Uniwersytet Szczeciński

autor

Jan Krakowiak

• Uniwersytet Medyczny w Łodzi

autor

Krzysztof Sieja

• Państwowa Wyższa Szkoła Zawodowa w Wałczu

Bibliografia

• Borowski A. (2016), Profilaktyka nowotworów [on-line], www.selenowanie.pl, dostęp: 7 11.2018.
• Clark L.C., Hixon L.J., Combs G.F., Reid M.E., Turnbull B.W., Sampliner R.E. (1993), Plasma selenium concentration predicts the prevalence of colorectal adenomatous polyps, "Cancer Epide- miol. Biomarker Prev.", z. 2, nr 19, ss. 41-46.
• Dennert G., Zwahlen M., Brinkman M., Vinceti M., Zeegers M.P, Horneber M. (2011), Sele- nium forpreventing eaneer(Review),"Cochrane Data Base Syst Rev", z. 32, nr 43, ss. 45-59.
• Dobrowolski J.W. (1995), Selen w ekologicznej profilaktyce środowiskowych zagrożeń zdrowia, I Międzynarodowa Konferencja, Obieg pierwiastków w przyrodzie - bioakumulaeja - toksyczność - przeciwdziałanie - integracja europejska, Warszawa, 15-17.09. 1995.
• El-Bayoumy K., Richie J.P., Boyiri T. Komninsu D., Prokopczyk B., Trushin N. (2002), Influence of selenium-enriched yeast supplementation on biomarkers of oxidative damage and hormone status in healthy adult males: a clinical pilot study, "Cancer Epidemiol. Biomarkers Prev.", z. 11, nr 25, ss. 1459-1465.
• Glauert H.P., Beaty M.M., Clark T.D., Greenwell W.S., Chew C.H. (1990), Effect of dietary selenium on the induction of altered hepatic foci and hepatic tumors by the peroxisome proliferator ciprofibrate, "Nutr. Cancer", z.14, nr 12, ss. 261-271.
• Ip C. (1985), Selenium inhibition of chemical carcinogenesis,"Fed. Proc.", z. 44, nr 32, ss. 2573-2579.
• Ip C., Daniel F.B. (1985), Effects of selenium on 7,12-dimethylbenzanthra dimethylbenz(a) anthracene - induced mammary carcinogenesis and DNA adduct formation, "Cancer Res." , z. 45, nr 15, ss. 61-65.
• Lane H.W., Teer P., Dukes J., Johnson J., White M.T. (1990), The effect of four chemical forms of selenium on mammary tumor incidence in BACB/C female mice treated with 7-12-dimethylbenz(a) anthracene, "Cancer Lett.", z. 50, nr 2, ss. 39-44.
• Le Boeuf R.A., Hoekstra W.G. (1985), Changes in cellular glutathione levels possible relation to selenium mediated anticarcinogenesis, "Fed. Proc.", z.44, nr 22, ss. 2563-2567.
• Lee E.H., Myung S.K., Jeon Y.J., Kim Y., Chang Y.J., Ju W., Seo H., Huh B.Y. (2011), Effects of Selenium supplementson cancer prevention: metaanalysis of randomized controlled trials, "Nutr. Cancer", z. 63, nr 14, ss. 1185-1195.
• Lei D.N., Wang L.Q., Ruebner B.H., Hsięeh D.P., Wu BF., Zhu CR., Du M.J. (1990), Effect of selenium on aflatoxin hepatocarcinogenesis in the rat, "Biomed. Environ. Sci.", nr 3, ss. 65-71.
• Lippman S.M., Klein E.A., Goodman P.J., Lucia M.S., Thompson I.M., Ford L.G., Parnes H.L., Minasian L.M., Gaziano J.M., Hartline J.A., Parsons J.K., Bearden J.D. (2009), Effect of sele- nium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT), "JAMA", z. 301, nr 1, ss. 39-51.
• Lubiński J., Huzarski T., Byrski T., Cybulski C., Stawicka M., Jakubowska A., Gronwald J., Górski B., Dębniak T., Wąsowicz W., Kilar E., Szwiec M., Surdyka D., Marczyk E., Serrano- Fernandez P., Sun P., Narod S.A. (2010), Adnexectomy status in the feature for association between serum selenium level and the risk of cancer in BRCA1 carriers, "Eur. J. Hum. Genet.", z. 18, nr 1, ss. 192-199.
• Minder W.E. (1991), Selen. Eigenschaften und medizinische Bedeutung dieses Spurenelementes, "DIAGM", z. 7, nr 16, ss. 635-640.
• Nyandieka H.S., Wakhisie J. (1993), The impact of vitamins A, C, E and selenium compound on prevention, "East Afr. Med. J.", z. 70, nr 2, ss. 151-158.
• Takada H., Hirooka T., Hatano T., Hamada Y., Yamamoto M. (1992), Inhibition of 7,12-dimethylbenz(a)anthracene - induced lipid peroxidation and mammary tumor development in rats by vitamin E in conjuction with selenium, "Nutr. Cancer", z. 17, nr 6, ss. 115-122.
• Waters D.J., Shen S., Cooley D.M., Bostwick D.G., Qian J., Combs J. (2003), Effects of dietary selenium on DNA damage and apoptosis in canine prostate, "J. Natl. Cancer Inst.", z. 95, nr 14, ss. 237-240.
• Wenzel G., Kukliński B., Ruhlmann Ch., Ehrhardt D. (1993), Alkoholtoxische Hepatitis - eine "freie Radikale" - assoziierte Erkrankung. Letatitatssenkung durch adjuvante Antioxidantienthera- pie, "Innere Medizin", z.48, nr 34, ss. 490-494.